PROSTATE CANCER: RADIATION APPROACHES for advanced disease

Slides:



Advertisements
Similar presentations
Long-Term Data for 884 Patients Show Vertebroplasty for Osteoporotic Spinal Fractures Provides Dramatic Pain Relief, Greatly Decreases Disability Giovanni.
Advertisements

PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
Introduction Treatment of metastatic prostate cancer with androgen deprivation therapy (ADT) is effective, but can be associated with debilitating side.
British Association of Urological Surgeons Metastatic Prostate Cancer Guidelines.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
Radiation Protection in Radiotherapy
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Radiofrequency Ablation of Lung Cancer
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Taylor J Greenwood, MD, Adam Wallace, MD, Aseem Sharma, MD, Jack Jennings, MD, PhD.
Waleed Awwad, MD, FRCSC. Red Flags: Red Flags: History of cancer History of cancer Unexplained weight loss >10 kg within 6 months Unexplained weight.
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
Radiotherapy for Kidney cancer
Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.
“Fighting Cancer: It’s All We Do.” ™. Restoring Quality of Life And Managing Side Effects Ulka Vaishampayan M.D. Chair, GU Multidisciplinary team Associate.
Living Beyond Breast Cancer Liver and Lung Metastases Workshop April 29, 2012 Paul B. Gilman, MDLankenau Medical Center.
Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon.
Prostate Cancer By: Kurt Rishel.
In the name of God Isfahan medical school Shahnaz Aram MD.
Conclusions HDR brachytherapy boost combined with moderate dose external beam irradiation resulted in a very high local control rate and few recurrences.
Howard M. Sandler, MD University of Michigan Medical School
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Low dose chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration resistant prostate cancer.
Hormone Refractory Prostate Cancer A Regulatory Perspective of End Points to Measure Safety and Efficacy of Drugs Hormone Refractory Prostate Cancer Bhupinder.
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
Mark L. Merlin, M.D. Radiotherapy Clinics of Georgia 7/14/2010 The Role of Radiation Therapy in the Management of Prostate Cancer.
Oncology Call Points & Disease State August 2009 For Internal Purposes Only * Do Not Copy * Do Not Distribute.
Reduced Pain and Improved Mobility Gained When Part of Treatment Plan for Vertebral Compression Fractures in Those With Multiple Myeloma Reduced Pain and.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Core Benefit/Risk (CR)
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Cancer, Exercise & Bone Health
High Dose Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian 1, Vivian Weinberg 3, Joycelyn.
Radiation Therapy Connective Tissue Oncology Society 2005 Thomas F. DeLaney, M.D.
Introduction to Radiation Therapy
Role of Radiation Therapy in Brain metastasis Bongkot Supawongwattana, M.D. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang.
Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Prostate Cancer Jay L. Friedland, MD.
Debra Freeman, MD – Naples Christopher King, MD, PhD - Stanford.
Laura Finucane Masqueraders course March 2012 Laura Finucane 2011 © Bony Metastases.
3. How do you intend to resolve the issue?. Approach to the patient Assure patient’s safety! Talk the patient out of committing suicide – Remind him that.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Radiation therapy for Early Stage Prostate Cancer
Background Results Patients and methods Conclusions References
Updates in Prostate Cancer Prepared for GP master class – Sept 2016
Bladder Cancer and Prostatic Cancer
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Prostate Cancer Jay L. Friedland, MD.
Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,
Jaden D. Evans, MD, Krishan R
Radiotherapy for Metastatic Spinal Cord Compression
Advances in the Treatment of Metastatic Prostate Cancer
CK RS for non-resectable pancreatic tumors
Nat. Rev. Urol. doi: /nrurol
Treatment Overview: The Multidisciplinary Team
Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.
Rarer Bone Tumors Thomas F. DeLaney, M.D. Co-Director: Sarcoma Program
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
History: 71 yo male post radical prostatectomy 4 years ago for Gleason 4+5 prostate cancer Pre-op staging CT and MDP bone scan were negative for metastatic.
Presentation transcript:

PROSTATE CANCER: RADIATION APPROACHES for advanced disease ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT

ARS ? ??

Advanced Disease Biochemical recurrence after prostatectomy Metastatic disease Palliative external RT Quadramet

Salvage Radiation Therapy for Biochemical Recurrence Recurrence>2years, PSA DT>10 months Positive margin, extracapsular extension Should be used early, PSA<1(possibly 0.5) 50-70% DFS in 5 years IMRT 60-70 Gy, image guidance daily acceptable early complications, rare late complications

Choo, R-Mayo Clinic 2009 IJROBP

Bone Metastasis Pain/loss of function One dominant site Multiple sites Spinal cord compression>emergency Hip metastasis causes pain, threatens fracture One dominant site Multiple sites

Spine radiation to osteoblastic lesion

Palliative Radiation Bone Metastasis Highly effective 90% or more for pain relief Can be repeated Short course of 2 weeks, occasionally even given in single dose, depending on location Can be combined with chemo, hormone deprivation, bone stabilization such as vertebroplasty or fusion if needed

Quadramet(samarium 153) Bone seeking radioisotope Systemic dose to “hot” areas Can combine with external May lower blood counts May cause “flare” Can last 3-6 months Can be repeated 60-75% response rate Best for patients with multiple or migratory painful sites

Advanced prostate cancer Team approach with urologist, medical and radiation oncologist Systemic therapies and local therapies Focus on disease control and quality of life Individually tailored THANK YOU!

Advanced Stage Disease Session Evaluation ? ??